XLXiao-Guang Li

Xiao-Guang Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiao-Guang Li has a total of 392 co-authors. Here are the top co-authors by number of shared publications:

  • Zhaoyang Yang

    Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, 100069 Beijing, China

    29 shared publications
  • Wen Zhao

    Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, 100069 Beijing, China

    22 shared publications
  • Lingying Wu

    Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

    19 shared publications
  • Jia-Sheng Rao

    Beijing Key Laboratory for Biomaterials and Neural Regeneration, National Medical Innovation Platform for Industry-Education Integration in Advanced Medical Devices (Interdiscipline of Medicine and Engineering), School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China

    18 shared publications
  • Peng Hao

    Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, 100069 Beijing, China

    17 shared publications
  • Can Zhao

    Institute of Rehabilitation Engineering, China Rehabilitation Science Institute

    14 shared publications

Latest Publications

  • Open Access

    Intravitreal delivery of NGF-chitosan hydrogel confers retinal ganglion cell protection and visual function recovery in experimental glaucoma

    by Limin Gao, Xiao Liu, Hongmei Duan, Peng Hao, Yudan Gao, Wen Zhao, Xunhui Guo, Huiting Jiang, Xinyue Ma, Kwok-Fai So, et al.

    Glaucoma is one of the leading causes of irreversible blindness, and lowering intraocular pressure alone is insufficient to rescue lost retinal ganglion cells (RGCs) or restore visual function. In this study, we intravitreally injected a liquid chitosan gel loaded with nerve growth factor (NGF), previously developed by our group, into the vitreous body of rats with ocular hypertension-induced glaucoma. Using a combination of techniques--including multiplex immunofluorescence staining, TUNEL staining, CTB tracing, Western blotting, visual electrophysiology, and behavioral assessments--we demonstrated that, compared with the lesion control (LC) group, the NGF-chitosan hydrogel significantly enhanced RGC survival following glaucomatous injury (by approximately 27%), preserved dendritic architecture and long-distance axonal projections, and promoted recovery of visual function. Mechanistically, treatment with the NGF-chitosan hydrogel upregulated the expression of NGF and its high-affinity receptor, tropomyosin receptor kinase A (TrkA), in the retina. In addition, it suppressed retinal glial activation and enhanced mammalian target of rapamycin (mTOR) signaling, collectively contributing to RGC protection and repair. Notably, we further observed activation of Nestin+ neural stem cells in the ciliary body region, along with their differentiation into BrdU+/Brn3a+ neuron-like cells; the precise mechanisms underlying this phenomenon warrant further investigation. In conclusion, intravitreal delivery of NGF-chitosan hydrogel provides novel mechanistic insights and represents a promising therapeutic strategy for the treatment of glaucoma.

  • Open Access

    Transient ocular hypertension drives delayed and IOP-independent retinal neurodegeneration

    by Xunhui Guo, Hongmei Duan, Huiting Jiang, Xinyue Ma, Hehang Shi, Lingrui Xu, Peng Hao, Yudan Gao, Wen Zhao, Zhaoyang Yang, et al.


  • Open Access

    BDNF-Hyaluronic Acid Hydrogel Promotes Neuronal Differentiation of Neural Stem Cells in Aβ-Induced Injury and 5×FAD Mice

    by Kangzhen Chen, Hehang Shi, Yuanyuan Bai, Shengbo Shi, Baoqing Gao, Hongmei Duan, Peng Hao, Wen Zhao, Yudan Gao, Zhaoyang Yang, et al.

    Objectives: Alzheimer’s disease (AD) is associated with impaired adult hippocampal neurogenesis (AHN). This study aimed to establish an in vitro model of Aβ1–42 oligomer-damaged neural stem cells (NSCs) and to employ the 5×FAD mouse model of AD in vivo, and to evaluate the therapeutic effects of brain-derived neurotrophic factor-loaded hyaluronic acid hydrogel (BDNF-HA gel) on AHN. Methods: In vitro, BDNF-HA gel was co-cultured with Aβ1–42 oligomer-impaired NSC spheres and evaluate NSC proliferation, migration, and differentiation. In vivo, BDNF-HA gel was infused intracerebroventricularly into 5×FAD mice. Using BrdU labeling, immunofluorescence, anterograde transsynaptic viral tracing, and behavioral tests, we assessed the effects of BDNF-HA gel on adult neurogenesis, newborn neuron integration into memory circuits, and cognitive function. Results: In vitro, BDNF-HA gel attenuated Aβ1–42-induced NSC apoptosis, restored proliferation and migration, promoted differentiation into neuroblasts, newborn neurons, and oligodendrocytes, and alleviated mitochondrial depolarization and loss of mitochondrial mass. In vivo, despite the absence of significant Aβ plaques reduction in 5×FAD mice, BDNF-HA gel markedly enhanced NSC proliferation and neurogenesis in the subventricular zone (SVZ) and subgranular zone (SGZ). Behavioral tests further revealed significant improvements in object recognition, spatial working memory, and spatial reference memory. Conclusions: BDNF-HA gel can effectively counteract the toxic microenvironment induced by Aβ oligomers, promoting NSC proliferation, migration, and differentiation into neurons. Without altering the Aβ burden, it significantly enhances adult neurogenesis and rescues cognitive deficits in AD mice.

  • Open Access

    Biomaterial gels drive endogenous neurogenesis to support functional recovery after adult traumatic cortical injury

    by Jinting Wu, Peng Hao, Hongmei Duan, Wen Zhao, Yudan Gao, Zhiqiang Cui, Zhaoyang Yang, Xiaoguang Li

    Activation and neuronal differentiation of endogenous neural stem/progenitor cells within the hippocampal neurogenic niche (a neurogenic region) of the adult mammalian brain are considered potential bases for restoration of cognitive and memory functions. However, following traumatic cortical brain injury (i.e., injuries in a non-neurogenic region), the local microenvironment becomes hostile due to the presence of inhibitory factors such as inflammation, edema, and hypoxic-ischemic stress. These conditions hinder the migration and subsequent neuronal differentiation of activated neural stem/progenitor cells into the injured cortex. Numerous recent studies have confirmed that biomaterials can improve the microenvironment of the injured area and promote nerve regeneration. In this study, we report the findings obtained by injecting a biodegradable chitosan-gelatin-collagen gel into the cortical lesion area. We observed that the chitosan-gelatin-collagen gel established a permissive microenvironment for neural repair by suppressing inflammation and scar infiltration while promoting neovascularization. Thus, it enabled activated endogenous "seed" cells, i.e., neural stem/progenitor cells, to migrate into the cortical lesion area and generate new neurons and thereby facilitate functional recovery. These findings represent a novel biomaterial-based therapeutic strategy for the treatment of traumatic cortical brain injury, stroke, and other neurological disorders.


  • Open Access

    Basic fibroblast growth factor sustained-release system promotes neurogenesis and tissue repair after spinal cord injury

    by Xuyang Fu, Hongmei Duan, Boya Zhang, Huan Wang, Yulin Bi, Miaoxin Yu, Peng Hao, Jian Sun, Dapeng Li, Yudan Gao, et al.

    Export Spinal cord injury is accompanied by a substantial loss of neurons. Cell replacement therapy improves motor and sensory dysfunction by replacing dead neurons, and endogenous neurogenesis is an important cell replacement source. Stimulating endogenous neurogenesis is therefore a viable approach for treating spinal cord injury. Given that basic fibroblast growth factor is a potent inducer of neurogenesis, we developed a sustained-release system of basic fibroblast growth factor-chitosan to enhance tissue repair in spinal cord injury. In the present study, we isolated neural stem cells from the spinal cords of neonatal rats and used single-cell RNA sequencing to trace the complete process of neurogenesis under ex vivo culture conditions. Under the influence of basic fibroblast growth factor-chitosan, neural stem cells were able to transition from a quiescent state to an activated state and subsequently differentiate into neuronal precursor cells and immature neurons. Additionally, basic fibroblast growth factor-chitosan significantly enhanced neural stem cell proliferation in vitro and promoted neuronal generation. Subsequent in vivo experiments confirmed the therapeutic efficacy of basic fibroblast growth factor-chitosan in spinal cord injury, demonstrating enhanced neurogenesis and tissue repair.

  • Open Access

    Vivid illusions and realtime feedback in VR-improved motor imagery and motivation of stroke patients with impaired motor imagery

    by Yanqing Xiao, Yang Gao, Hongming Bai, Ning Li, Xiao E. Cai, Jia-Sheng Rao, Aimin Hao, Xiaoguang Li, Jia Zheng

    Virtual reality (VR) enhances subjective imagery experience. However, no previous studies have investigated whether VR can improve subjective imagery experience in stroke patients who specifically present with motor imagery (MI) impairment. The present work aimed to examine the effect of interactive virtual reality on subjective imagery experience in such a patient population. Twenty-eight stroke patients with hemiplegia who were specifically recruited based on objectively assessed motor imagery impairment (as measured by the KVIQ-10) participated in the study. Following interactive VR training, all subjects completed questionnaires assessing subjective imagery experience, sense of embodiment, motivation, and adverse reactions. A 1-week follow-up was conducted. The results showed that these patients with pre-existing MI impairment did not differ from the healthy control group in terms of sense of embodiment or subjective imagery experience under VR conditions. Furthermore, the patient group demonstrated significantly higher system acceptance in motivation assessments compared to the healthy controls. Most patients voluntarily recalled the VR scenes during the follow-up week, whereas participants in the control group did not. These findings indicate that stroke patients with overt motor imagery deficits can benefit from the proposed VR rehabilitation system, supporting its potential for further development in VR-based neurorehabilitation programs.


  • Effects of NGF-chitosan on alleviating secondary degeneration and repairing primary degeneration after expanded partial optic nerve transection

    by Xiao Liu, Hongmei Duan, Limin Gao, Linhao Yuan, Peng Hao, Wen Zhao, Yudan Gao, Zitian Huang, Xi Wang, Wenjianlong Zhou, et al.

    Optic neuropathy is one of the main causes of irreversible blindness in the world, and there is no effective treatment in clinic. Both primary degeneration and secondary degeneration play an important role in the injury caused by optic neuropathy. Partial optic nerve transection (PONT) model can be used to study these two kinds of degeneration simultaneously. However, there is currently no measure that can effectively intervene in both types of injuries concurrently. Here, we constructed an expanded partial optic nerve transection (EPONT) model. Nerve growth factor (NGF)-chitosan locally implanted into the injured area could simultaneously intervene in the secondary and primary degeneration, not only protecting the ventral part of the injured optic nerve, but also promoting the regeneration of the dorsal part. Visual functions, including pupillary light reflex and depth perception, were also well preserved. NGF-chitosan exerted biological effects by enhancing the expression of NGF and tyrosine kinase A (TrkA) in the optic nerve and retinal ganglion cells (RGCs). Furthermore, NGF-chitosan played a protective and repairing role by inhibiting the activation of microglia in the ventral area of the injured optic nerve and increasing the expression of mammalian target of rapamycin (mTOR) in RGCs. Our results demonstrate that the local use of NGF-chitosan in the injured area effectively repaired the optic nerve, which provides a new measure for the clinical treatment of optic nerve injury.


  • Open Access

    bFGF-Chitosan “brain glue” promotes functional recovery after cortical ischemic stroke

    by Jiao Mu, Xiang Zou, Xinjie Bao, Zhaoyang Yang, Peng Hao, Hongmei Duan, Wen Zhao, Yudan Gao, Jinting Wu, Kun Miao, et al.

    The mammalian brain has an extremely limited ability to regenerate lost neurons and to recover function following ischemic stroke. A biomaterial strategy of slowly-releasing various regeneration-promoting factors to activate endogenous neurogenesis represents a safe and practical neuronal replacement therapy. In this study, basic fibroblast growth factor (bFGF)-Chitosan gel is injected into the stroke cavity. This approach promotes the proliferation of vascular endothelial cell, the formation of functional vascular network, and the final restoration of cerebral blood flow. Additionally, bFGF-Chitosan gel activates neural progenitor cells (NPCs) in the subventricular zone (SVZ), promotes the NPCs’ migration toward the stroke cavity and differentiation into mature neurons with diverse cell types (inhibitory gamma-aminobutyric acid neurons and excitatory glutamatergic neuron) and layer architecture (superficial cortex and deep cortex). These new-born neurons form functional synaptic connections with the host brain and reconstruct nascent neural networks. Furthermore, synaptogenesis in the stroke cavity and Nestin lineage cells respectively contribute to the improvement of sensorimotor function induced by bFGF-Chitosan gel after ischemic stroke. Lastly, bFGF-Chitosan gel inhibits microglia activation in the peri-infarct cortex. Our findings indicate that filling the stroke cavity with bFGF-Chitosan “brain glue” promotes angiogenesis, endogenous neurogenesis and synaptogenesis to restore function, offering innovative ideas and methods for the clinical treatment of ischemic stroke.


  • Open Access

    Impact of an upper limb motion-driven virtual rehabilitation system on residual motor function in patients with complete spinal cord injury: a pilot study

    by Yanqing Xiao, Yang Gao, Hongming Bai, Guiyun Song, Hanming Wang, Jia-Sheng Rao, Aimin Hao, Xiaoguang Li, Jia Zheng

    Assessing residual motor function in motor complete spinal cord injury (SCI) patients using surface electromyography (sEMG) is clinically important. Due to the prolonged loss of motor control and peripheral sensory input, patients may struggle to effectively activate residual motor function during sEMG assessments. The study proposes using virtual reality (VR) technology to enhance embodiment, motor imagery (MI), and memory, aiming to improve the activation of residual motor function and increase the sensitivity of sEMG assessments. By Recruiting a sample of 12 patients with AIS A/B and capturing surface electromyographic signals before, druing and after VR training, Most patients showed significant electromyographic improvements in activation frequency and or 5-rank frequency during or after VR training. However, one patient with severe lower limb neuropathic pain did not exhibit volitional electromyographic activation, though their pain diminished during the VR training. VR can enhance the activation of patients’ residual motor function by improving body awareness and MI, thereby increasing the sensitivity of sEMG assessments.


  • Open Access

    Activation of adult endogenous neurogenesis by a hyaluronic acid collagen gel containing basic fibroblast growth factor promotes remodeling and functional recovery of the injured cerebral cortex

    by Yan Li, Peng Hao, Hongmei Duan, Fei Hao, Wen Zhao, Yudan Gao, Zhaoyang Yang, Kwok-Fai So, Xiaoguang Li

    JOURNAL/nrgr/04.03/01300535-202510000-00024/figure1/v/2026-04-25T153616Z/r/image-tiff The presence of endogenous neural stem/progenitor cells in the adult mammalian brain suggests that the central nervous system can be repaired and regenerated after injury. However, whether it is possible to stimulate neurogenesis and reconstruct cortical layers II to VI in non-neurogenic regions, such as the cortex, remains unknown. In this study, we implanted a hyaluronic acid collagen gel loaded with basic fibroblast growth factor into the motor cortex immediately following traumatic injury. Our findings reveal that this gel effectively stimulated the proliferation and migration of endogenous neural stem/progenitor cells, as well as their differentiation into mature and functionally integrated neurons. Importantly, these new neurons reconstructed the architecture of cortical layers II to VI, integrated into the existing neural circuitry, and ultimately led to improved brain function. These findings offer novel insight into potential clinical treatments for traumatic cerebral cortex injuries.